cancer detection — LDV Capital Blog on Visual Technologies and AI — LDV Capital
LDV Blog
Automation is revolutionizing legacy industries from healthcare and precision medicine to manufacturing and construction, to agriculture and sustainability. The adoption of visual technology innovations will continue to remain the crux of automation for the next decade and beyond.
Emi Gal, co-founder & CEO of Ezra, our portfolio company, showcases the tech his company is utilizing to detect prostate cancer and how he believes computer vision will revolutionize MRI-based cancer screening.
Experts from Harvard Medical School, Facebook AI Research, Pearl, and LDV Capital discuss trends of computer vision and machine learning impact on medical diagnostics to revolutionize precision medicine.
In this article, Emi Gal talks about how Ezra is changing the game for cancer detection through visual technology. Read on to learn about his scientific research-driven approach, the long-term possibilities for Ezra.